Challenges to indian biotech industry


Published on

  • Be the first to comment

No Downloads
Total Views
On Slideshare
From Embeds
Number of Embeds
Embeds 0
No embeds

No notes for slide

Challenges to indian biotech industry

  2. 2. Contents<br />Biotechnology and India<br />Indian market<br />SWOT analysis<br />Challenges faced<br />Biotech business in India<br />Ipr &biotech industry<br />Future of Indian biotech sector<br />
  3. 3. BIOTECHNOLOGY AND INDIA<br />Quite nascent stage.<br />Biodiversity of India is an advantage for biotech sector.<br />Over 300 registered biotech companies, out of which 100 are in modern biotech sector.<br />12th most successful biotech sector in world,<br />3rd largest in Asia with 96 enterprises(after Australia and china).<br />
  4. 4. INDIAN BIOTECH MARKET<br />Total biotech sectors: $420 million in 2002-03.<br />Vaccines : bharat biotech, shanta biotech,pfizer, panacea,etc.<br />Therapeutics : biocon, eli lily, etc.<br />Diagnostics : span diagnostics,j.mitra, xcyton <br />
  5. 5.
  6. 6.
  7. 7. SWOT ANALYSIS<br />Strength, weakness , opportunity, threats,<br />Best way to make critical analysis of scientific research in country.<br />
  8. 8. STRENGTH:<br />Human Resource: Trained manpower and knowledge base.<br />•Academic Resource: Good network of research laboratories.<br />•Industry Base: Well developed base industries (e.g. pharmaceuticals, seeds).<br />•International Experts: Access to intellectual resources of NRI’s in this area.<br />•Clinical Capability: Extensive clinical trials and research access to vast and diverse disease in the huge population.<br />•Bio-diversity: India’s human gene pools and unique plant, animal & microbial diversity offer an exciting opportunity for genomic research.<br />•Stem Cells Research: Several labs have commenced research in stem cells and have valuable stem cell lines.<br />
  9. 9. Weakness<br />Indian Biotechnology: Weakness<br />Missing link between research and commercialization<br />•Lack of venture capital<br />•Relatively low R&D expenditure by industry<br />•Image of Indian industry –doubts about ability of Indian products to meet International standards of quality<br />
  10. 10. Opportunities<br />indian Biotechnology: Opportunities<br />•Large domestic market<br />•Large export potential<br />•Low cost research base for international companies in comparison with other countries<br />•Vast and diverse disease based patient populations provide unique opportunities for clinical research and clinical trials <br />•Supportive Government policy on embryonic stem cells research provides a useful opportunity for International companies to pursue such research in India<br />•Human bio-diversity provides unique research opportunity in genomics<br />•Plant & microbial bio-diversity provides vast prospecting opportunities for new drugs<br />•Conducive Government policy on GM crops provides useful opportunities for Agri-biotech companies<br />
  11. 11. Threats<br />Exodus of brilliant brain to other countries.<br />Enhanced level of politics in system.<br />Improper utilization of enormous funds.<br />Lack of scientific responsibility among young scientist.<br />
  12. 12. Challenges faced by indian biotechnological sector<br />Weak entrepreneurial skills<br />Lack of quality human resource<br />Lack of public private partnership.<br />Risk averse nature of industry.<br />Lack of venture funding<br />
  13. 13. Lack of ignition grant system.<br />Streamlining the regulatory process.<br />Time to market.<br />Poor feasibility of indian market.<br />Partnership with pharmaceutical industry.<br />
  14. 14. Business in india<br />Joint venture<br />Collaborative research.<br />Contract research<br />Technology transfer<br />Clinical research.<br />
  15. 15. IPR and the Biotech Industry<br />Ipr importance<br />•IP is a central issue in any industry<br />•Robust intellectual property rights framework is the need of the hour<br />•India is already member of <br />–Paris Convention<br />–PCT<br />–Berne Convention<br />–Convention on biological diversity<br />–WTO<br />•Should make legislation clear on the criteria for the patentability of biotechnological inventions<br />
  16. 16. Ipr scenario in India(challenges):<br /> need to improve patent legislation<br /> infrastructure needs attention<br /> till 2005 only process were granted patent.<br /> poor patent protection & litigation attracts<br /> less foreign ventures.<br /> inefficient indian judicial system.<br />
  17. 17. What can be Claimed?<br />–Diagnostic tests<br />–Research tools<br />–Gene therapy<br />–Therapeutic proteins Sensors<br />–Bioinformatics<br />–Sequences<br />–Pharmaceuticals<br />
  18. 18. The future of Biotechnology<br />•Developing diverse, collaborative relationships to strengthen its industry<br />•Harmonizing standards with international standards in manufacturing and laboratory practices (ensuring foreign markets and enhancement of the industry’s global and local standing)<br />•Cheaper labor, technical capacity and expertise may capture markets away from companies in the developed countries<br />•Illustrates the importance of fostering a regulatory and IP environment (encouraging innovative startup companies)<br />
  19. 19. THANK YOU!!!!<br />
  1. A particular slide catching your eye?

    Clipping is a handy way to collect important slides you want to go back to later.